ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.

By D. Wright, A. Kellermann, V. Hertzberg, P. L. Clark, Michael R. Frankel, F. Goldstein, J. Salomone, L. Dent, O. Harris, D. Ander and 8 more. Annals of Emergency Medicine, 2007

603 citations recorded by the source corpus.

Subfields: Epidemiology, Molecular Biology, Neurology

View Paper: https://www.semanticscholar.org/paper/2f5839143aa7dc4aebe06ffe8c013dfec2690420

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Brinton
2. Richard F. Thompson
3. M. Foy
4. C. Finch
5. C. Pike
6. Junming Wang
7. M. Baudry
8. W. Mack

Citations in the corpus

• Progesterone receptors: form and function in brain. (2008, positive): “In recent years, both of these extrahypothalamic sites have garnered increasing interest from endocrinologists based on accumulating evidence that P4 has potent and direct neuroprotective and neuroregenerative effects in these brain regions while also regulating estrogen action [20,44,91,94, 102,127”
• Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. (2012, neutral): “Despite the perceived limitations of the preclinical research, two randomized, double-blind, placebo-controlled phase II clinical trials for progesterone have been conducted (Wright et al., 2007; Xiao et al., 2008).”